kabutan

KAKEN PHARMA, Apr-Jun (1Q) Ordinary Profit Decreases by 86%

Thu Aug 7, 2025 3:30 pm JST Earnings

4521 KAKEN PHARMACEUTICAL CO.,LTD. 【J-GAAP】

Earnings Report

KAKEN PHARMACEUTICAL CO.,LTD. <4521> [TSE Prime] announced its financial results after the market closed on August 7th (15:30). The consolidated ordinary profit for the first quarter of the fiscal year ending March 2026 (April to June) significantly dropped 86.2% from the same period last year to 0.41 billion yen. Progress toward the full-year plan of 6.00 billion yen was 7.0%, also falling below the five-year average of 30.8%.

In the most recent three-month period, from April to June (1Q), the operating profit margin sharply declined from 15.1% in the same period last year to 0.1%.

Kabutan News

Actual Results

Accumulated Results 1st Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Apr - Jun, 2023 18,150 3,293 3,488 2,510 67.0 61.0 Aug 4, 2023 J-GAAP
Apr - Jun, 2024 18,254 2,750 3,011 1,754 46.3 15.2 Aug 7, 2024 J-GAAP
Apr - Jun, 2025 18,867 14 417 271 7.1 ー Aug 7, 2025 J-GAAP
YoY +3.4% -99.5% -86.2% -84.5% -84.6%

Current Period Guidance

H1 Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Apr - Sep, 2024 51,372 19,579 19,823 14,286 377.2 115 Nov 8, 2024 J-GAAP
Apr - Sep, 2025 Guidance ー ー ー ー － 95 May 12, 2025 J-GAAP
YoY － － － － －

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Mar, 2024 72,044 9,513 9,951 8,025 212.7 150 May 14, 2024 J-GAAP
Mar, 2025 94,035 21,034 21,279 13,945 365.4 190 May 12, 2025 J-GAAP
Mar, 2026 Guidance 88,000 5,200 6,000 3,400 89.8 190 May 12, 2025 J-GAAP
YoY -6.4% -75.3% -71.8% -75.6% -75.4%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Apr - Jun, 2024 18,254 2,750 3,011 1,754 46.3 15.1 Aug 7, 2024 J-GAAP
Jul - Sep, 2024 33,118 16,829 16,812 12,532 330.9 50.8 Nov 8, 2024 J-GAAP
Oct - Dec, 2024 24,618 5,841 6,258 4,889 129.1 23.7 Feb 6, 2025 J-GAAP
Jan - Mar, 2025 18,045 -4,386 -4,802 -5,230 -137.1 -24.3 May 12, 2025 J-GAAP
Apr - Jun, 2025 18,867 14 417 271 7.1 0.1 Aug 7, 2025 J-GAAP
YoY +3.4% -99.5% -86.2% -84.5% -84.6%

Related Articles